Two Sigma Investments »

An2 Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $306k 94k 3.25
2023-12-31 $394k 19k 20.49

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Netflix (NFLX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Paypal Holdings (PYPL)
Crowdstrike Hldgs Cl A (CRWD)
Bristol Myers Squibb (BMY)
Pepsi (PEP)
Robinhood Mkts Com Cl A (HOOD)
Humana (HUM)
Wal-Mart Stores (WMT)
Occidental Petroleum Corporation (OXY)
Gilead Sciences (GILD)

View all positions for Two Sigma Investments

Top funds holding An2 Therapeutics

RA Capital Management
Citadel Advisors
Frazier Life Sciences Management
BVF
Henderson Group
Avidity Partners Management
Octagon Capital Advisors
Vanguard Group
Adage Capital Partners GP
BlackRock
Susquehanna International
Geode Capital Management
Acadian Asset Management
Walleye Trading Advisors
Alyeska Investment Group

View all funds holding An2 Therapeutics